Clinical Trial Update: Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations

View source ↗

Summary

This clinical trial update describes a study evaluating responses to genetic risk modifier testing in women with BRCA1/2 mutations; the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Genetic Testing, BRCA1/2 | Status: RECRUITING